eGFR is More Accurate Than Estimated Creatinine Clearance and Serum Creatinine Alone
Use serum creatinine-based eGFR (eGFRcr) as your initial assessment of kidney function, not estimated creatinine clearance (eCrCl) or serum creatinine alone 1.
The Hierarchy of Accuracy
The 2024 KDIGO guidelines establish a clear algorithmic approach to kidney function assessment 1:
Initial Assessment
- Start with eGFRcr (creatinine-based estimated GFR using equations like CKD-EPI) as your first-line test
- Serum creatinine alone is inadequate and should never be used in isolation for clinical decision-making
- The Cockcroft-Gault equation (which estimates creatinine clearance, not GFR) is outdated for most clinical purposes
When More Accuracy is Needed
If eGFRcr is thought to be inaccurate or critical decisions depend on precise GFR assessment:
- Add cystatin C and calculate eGFRcr-cys (combined creatinine-cystatin C equation)
- This combined approach is more accurate than either marker alone 1
Gold Standard Confirmation
For the highest accuracy when treatment decisions critically depend on precise GFR:
- Measure GFR directly using plasma or urinary clearance of exogenous filtration markers
- This is the true gold standard, superior to all estimation methods
Why eGFR Beats Creatinine Clearance
The Evidence Against Cockcroft-Gault
The 2024 NKF consensus explicitly recommends transitioning away from Cockcroft-Gault estimated creatinine clearance (C-G eCrCl) to race-free eGFR equations for medication dosing and all clinical decisions 2. The FDA now recommends eGFR over C-G eCrCl for evaluating pharmacokinetics in patients with impaired kidney function 2.
Research consistently shows:
- In critically ill patients: All predictive equations have limitations, but when comparing methods, eGFR equations perform comparably or better than estimated creatinine clearance 3, 4
- For drug dosing: The shift from Cockcroft-Gault to eGFR provides more accurate and consistent assessment across healthcare settings 2
- 24-hour urine creatinine clearance (the measured version, not estimated) has poor correlation with eGFR formulas, with weak agreement that makes them non-equivalent 5
Serum Creatinine Alone is Insufficient
Serum creatinine by itself is not sensitive enough to detect early kidney function loss 6. It fails to account for:
- Age-related changes in muscle mass
- Sex differences in creatinine generation
- Body size variations
- Race/ethnicity factors (though newer equations are race-free)
Clinical Implementation Algorithm
For routine clinical practice:
Use race-free CKD-EPI 2021 equation (eGFRcr) as your initial test 7, 2
If eGFRcr may be inaccurate due to:
- Extremes of muscle mass (very low or very high)
- Malnutrition, cancer, heart failure, cirrhosis
- Unusual diets (vegetarian, high-protein, ketogenic)
- Critical illness
Then: Add cystatin C and use eGFRcr-cys 1
If even more accuracy is needed for critical decisions (e.g., living kidney donor evaluation, chemotherapy dosing):
- Measure GFR directly with exogenous markers 1
For medication dosing specifically:
- Use eGFR adjusted for individual body surface area when BSA differs significantly from 1.73 m² 2
- Discontinue use of Cockcroft-Gault for this purpose 2
Common Pitfalls to Avoid
- Don't rely on serum creatinine alone - it misses early kidney dysfunction and doesn't account for patient-specific factors
- Don't use Cockcroft-Gault routinely - it's outdated and less accurate than modern eGFR equations 2
- Don't assume 24-hour urine creatinine clearance is more accurate - it has collection errors, poor patient compliance, and doesn't correlate well with eGFR 5
- Don't ignore situations where eGFRcr is inaccurate - extremes of muscle mass, acute illness, and certain chronic conditions require cystatin C confirmation 1
The Bottom Line on Accuracy
eGFR using modern equations (CKD-EPI 2021) > estimated creatinine clearance (Cockcroft-Gault) > serum creatinine alone for assessing kidney function in clinical practice 1, 2. When higher accuracy is required, add cystatin C to calculate eGFRcr-cys, or measure GFR directly with exogenous markers 1.